Home / Focus & sleep / Selank
SaHuman trials

Selank

Selank is a lab-made peptide based on tuftsin, a natural immune peptide. In Russia it is sold as nasal drops for anxiety and stress. It is not approved in the US or EU.

Registered in Russia · Selank 0.15% nasal dropsNot approved in the US or EU
OverviewDosingMixingResearchCommunitySafetyFAQSources

Selank quick reference

TypeTuftsin-analog peptide (7 amino acids)
Studied forAnxiety, stress, memory
EvidenceSmall Russian human trials, no placebo arm found
RouteNasal drops (Russia); injection is community only
Half-lifeNot established in people

What is Selank?

Lab-made peptide built from tuftsin plus Pro-Gly-Pro.

Sold in Russia as prescription nasal drops for anxiety.

Not approved in the US or EU; trials are small.

How Selank works

Enkephalin breakdown

In blood samples, it slowed enzymes that break down calming enkephalins.

GABA-related genes (rats)

In rat frontal cortex it changed 45 neurotransmission genes within an hour.

Cells in a dish

Alone, it changed none of the genes tested in nerve-cell cultures.

Brain scans

In 52 healthy adults, it shifted amygdala–temporal cortex connectivity.

What Selank is studied for

PeopleGeneralized anxiety

62 patients: Selank eased anxiety about as well as medazepam.

PeopleAnxiety vs phenazepam

60 patients: anxiety relief lasted a week after the last dose.

PeopleAdd-on to phenazepam

70 patients: fewer sedative side effects when Selank was added.

PeopleBrain scans

52 healthy adults: connectivity between right amygdala and temporal cortex shifted.

AnimalsMemory in rats

Selank prevented alcohol-linked memory loss and BDNF changes.

AnimalsGene activity in rats

Changed GABA-related and other neurotransmission genes in frontal cortex.

Selank dosing protocol

ItemRussian label (0.15% nasal drops)
Strength1.5 mg per mL
Dose2 drops in each nostril, 3 times a day (12 drops a day)
Course14 days
RepeatAfter 1 to 3 weeks, with a doctor
Drop sizeNot stated on the label

From the Russian drug reference RLS (Selank entry, Peptogen, registration number ЛП-№(010951)-(РГ-RU)). Nasal use only. The label does not give a daily amount in mcg.

LABEL (0.15% DROPS)2 drops per nostril, 3 times dailyLabel
LABEL COURSE14 days; repeat after 1–3 weeksLabel
COMMUNITY RANGE200–400 mcg, 2–3 times dailyCommunity
COMMUNITY CYCLE2 weeks onCommunity
TIMINGMorning to early afternoonCommunity

Label and trial amounts come from the sources below. Community amounts are what people report; they have not been tested.

Mixing

Vial10 mg
+
BAC water5 mL
=
Strength2 mg per mL

Community nasal example. One 0.1 mL spray = 200 mcg; check your pump.

Open the peptide calculator

What the research found

Small Russian studies in anxiety, compared with older anxiety drugs. The abstracts do not give effect sizes. I found no placebo-controlled trial.

62Patients with generalized anxiety or neurasthenia (2008): Selank (30) and medazepam (32) eased anxiety about equally
60Patients with anxiety disorders (2014), Selank vs phenazepam: Selank's effect lasted a week after the last dose
70Patients (2015): Selank added to phenazepam (40) vs phenazepam alone (30); fewer drug side effects with Selank

Zozulia AA et al. 2008 (PMID 18454096); Medvedev VE et al. 2014 (PMID 25176261) and 2015 (PMID 26356395). All in Zh Nevrol Psikhiatr Im S S Korsakova, Russian-language papers.

Selank community experience

What users report. Not tested in trials.

Positive reports

  • Calm, not sedated Most common report: less background anxiety without a medicated feel.
  • Less tension Some feel less muscle tension and fewer racing-heart moments.
  • Easier recall Better word recall and working memory are often mentioned.
  • Gentle effect Described as subtle, neither stimulating nor sleepy.

Negative & mixed

  • No effect Some notice nothing, often with weak nasal products.
  • Severe anxiety Less reliable for panic or severe social anxiety.
  • Side complaints Headache, tiredness, dizziness or nasal irritation now and then.
  • Odd timing Onset ranges from 10 minutes to two weeks; late doses hurt winding down.

Selank stacking

Selank + Semax

Calm plus focus. Each studied alone in a brain-scan study, never as a stack.

Selank + phenazepam

Studied in 70 patients under a doctor: fewer sedative side effects.

Selank + BPC-157

Used for separate goals. No evidence of synergy.

Selank side effects & safety

Common

  • Allergic reactions, including delayed ones (label).
  • Unpleasant taste when drops run down the throat (label).
  • Nasal irritation (community).
  • Headache or mild tiredness (community).

Less common

  • Dizziness or nausea (community).
  • Restlessness or vivid dreams (community).
  • Redness or bruising at injection sites (community).

Precautions

  • Label: avoid in pregnancy, breastfeeding and under age 18.
  • Alcohol, sedatives or benzodiazepines: combined use studied only in clinics.
  • Psychiatric drugs: no interaction program exists.
  • No large trial measured safety.
  • Not a substitute for care in panic, mania or crisis.

Our verdict on Selank

More human data than most nootropic peptides. Trials are small, Russian, and none I found had a placebo arm.

Selank FAQ

Is Selank a benzodiazepine?

No. It is a tuftsin-based peptide. In one trial, adding it cut phenazepam side effects.

How is Selank taken?

Label: nasal drops for 14 days. Injection has no source.

Does Selank cause dependence?

I found no trial that measured dependence. Studies were short.

Selank or Semax?

Selank is studied for anxiety. Semax is studied for stroke and thinking.

Sources

  • RLS (rlsnet.ru) Selank 0.15% nasal drops entry, Peptogen
  • Zozulia AA et al. Zh Nevrol Psikhiatr 2008;108(4):38-48, PMID 18454096
  • Medvedev VE et al. Zh Nevrol Psikhiatr 2014;114(7):17-22, PMID 25176261
  • Medvedev VE et al. Zh Nevrol Psikhiatr 2015;115(6):33-40, PMID 26356395
  • Enkephalin-degrading enzymes and Selank. Bull Exp Biol Med 2001, PMID 11550013
  • Selank and ethanol-induced memory impairment in rats (BDNF). Bull Exp Biol Med 2019, PMID 31625062
  • ClinicalTrials.gov search by intervention name, run 5 Nov 2026: no Selank peptide trials
  • Selank and GABA-related gene expression in rat frontal cortex. Front Pharmacol 2016, PMID 26924987
  • Selank, GABA and olanzapine in IMR-32 cells. Front Pharmacol 2017, PMID 28293190
  • Functional connectomic approach to Selank and Semax. Dokl Biol Sci 2020, PMID 32342318
  • Community reports summarised from public peptide-community notes (peptideprotocols.app page); user reports, not research